• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

susanne.ramm@unimelb.edu.au

Credentials


Position
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology

Dr Susanne Ramm

Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology

23 Scholarly works
3 Projects

HIGHLIGHTS

  • 2025

    Journal article

    macpie: Scalable workflow for high-throughput transcriptomic profiling
    DOI: 10.1016/j.csbj.2025.11.002
  • 2024

    Journal article

    CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancer
    DOI: 10.1038/s41416-024-02810-8
  • 2024

    Journal article

    A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
    DOI: 10.1093/nargab/lqae096
  • 2024

    Research grants (other domestic)

    Preclinical Validation of New Therapeutics for Low-Grade Serous Ovarian Cancer
  • 2024

    Journal article

    Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer
    DOI: 10.1002/path.6280
  • 2024

    Journal article

    INX-315, a Selective CDK2 Inhibitor, Induces Cell Cycle Arrest and Senescence in Solid Tumors
    DOI: 10.1158/2159-8290.CD-23-0954
  • 2023

    Journal article

    High-Throughput Live and Fixed Cell Imaging Method to Screen Matrigel-Embedded Organoids
    DOI: 10.3390/organoids2010001
Susanne Ramm

RECENT SCHOLARLY WORKS

  • 2023

    Journal article

    MAC-Seq: Coupling Low-Cost, High-Throughput RNA-Seq with Image-Based Phenotypic Screening in 2D and 3D Cell Models
    DOI: 10.1007/978-1-0716-3331-1_22
  • 2023

    Journal article

    Radiation therapy attenuates lymphatic vessel repair by reducing VEGFR-3 signalling
    DOI: 10.3389/fphar.2023.1152314
  • 2021

    Journal article

    Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
    DOI: 10.1038/s41598-021-84194-w
  • 2021

    Journal article

    CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition
    DOI: 10.1158/1535-7163.MCT-20-0932

RECENT PROJECTS

  • Research Grant

    ComBATing Lethal Prostate Cancer With Combination Bipolar Androgen Therapy
  • Research Grant

    ComBATing Lethal Prostate Cancer With Combination Bipolar Androgen Therapy

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224